Research paper
5-Fluorouracil: various kinds of loaded liposomes: encapsulation efficiency, storage stability and fusogenic properties

https://doi.org/10.1016/0378-5173(93)90356-KGet rights and content

Abstract

This paper describes the optimization of 5-fluorouracil (5-FU) loaded liposome formulations. Four different preparation procedures were carried out, obtaining two types of multilamellar vesicles (MLVs), stable plurilamellar vesicles (SPLVs) and large unilamellar vesicles (LUVs). In this study various phospholipids were used to prepare liposomes. The lipid mixtures containing diplamitoylphosphatidylserine seemed the best for biological 5-FU delivery by presenting better encapsulation efficiency parameters, serum and storage stability, and fusogenic properties, which are an important factor prerequisite for in vivo liposome-cell interaction. The presence of cholesterol in the liposome composition was an important factor thereby ensuring serum and storage stability of the various vesicular systems. The most suitable liposome preparation was the SPLVs, that showed both good drug loading and stability parameters, compared to LUVs which had the highest loading capacity but low serum and storage stability.

References (44)

  • A.Y. Ozer et al.

    Preparation and stability of liposomes containing 5-fluorouracil

    Int. J. Pharm.

    (1989)
  • H. Sasaki et al.

    Characterization of alkylcarbamoyl derivatives of 5-fluorouracil and their application to liposome

    Int. J. Pharm.

    (1987)
  • P.L. Stetson et al.

    Sensitive high-performance liquid chromatographic method for the determination of 5-fluorouracil in plasma

    J. Chromatogr.

    (1985)
  • J.C. Stewart et al.

    Anal. Biochem.

    (1980)
  • R.M. Straubinger et al.

    pH-sensitive liposome mediate cytoplasmic delivery of encapsulated macromolecules

    FEBS Lett.

    (1985)
  • R.M. Straubinger et al.

    Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after interaction in coated vesicles

    Cell

    (1983)
  • A. Vainstein et al.

    A new method for reconstitution of highly fusogenic Sendai virus envelopes

    Biochim. Biophys. Acta

    (1984)
  • N. Ackerman

    Experimental studies on the role of the portal circulation in hepatic tumourvascularity

    Cancer

    (1986)
  • S. Benita et al.

    Radiopaque liposomes: effect of formularion conditions on encapsulation efficiency

    J. Pharm. Sci.

    (1984)
  • A.D. Bangham et al.

    Diffusion of univalent ions across the lamellar of swollen phospholipids

    J. Mol. Biol.

    (1965)
  • F. Castelli et al.

    Calorimetric studies of the interaction of 4-biphenylacetic acid and its βcyclodextrin inclusion compound with lipid model membrane

    Int. J. Pharm.

    (1989)
  • B.A. Chabner

    Pyrimidine antagonist

  • Cited by (53)

    • Functionally engineered ‘hepato-liposomes’: Combating liver-stage malaria in a single prophylactic dose

      2020, International Journal of Pharmaceutics
      Citation Excerpt :

      The liposomes are seen as light spherical structures against a dark background created by the heavy metal stain. The dark and light shades are evident due to the remnants of the contrast agent employed for negative staining (Fresta et al., 1993). The images clearly indicate that DQN incorporation did not influence the spherical morphology of SAG modified vesicles and their size was in concordance with the DLS data shown in table 2.

    • Encapsulation of elderberry extract into phospholipid nanoparticles

      2015, Journal of Food Engineering
      Citation Excerpt :

      The aqueous medium surrounding the liposomes is replaced with an appropriate buffer in the later stage of the process. Thus, the EE of water soluble compounds into liposomes is reported to be less than 10%, regardless of the liposome type (Fresta et al., 1993; Elorza et al., 1993; Sasaki et al., 1987) or membrane properties (El Maghraby et al., 2001). However, it was proved, that the EE can be significantly increased by employing proper production technique (Tomoko and Fumiyoshi, 2005).

    • Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy

      2011, Journal of Controlled Release
      Citation Excerpt :

      Several approaches have been developed to address the issues of extended 5-FU exposure time, catabolism by dihydropyrimidine dehydrogenase (DPD) and 5-FU toxicity. These include the use of prodrugs, biomodulation and drug delivery methods such as liposomes/polymer-nanoparticles [2–11]. The most successful approach to date has been the development of a pro-drug where the parent drug (capecitabine) is enzymatically converted to the active metabolite in the target tissues.

    • Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas

      2007, Journal of Dermatological Science
      Citation Excerpt :

      This may have contributed to the highly negative charge of PE liposomes (−54.9 mV). The profiles of the zeta potential may explain the smaller size of PE liposomes compared to EPC liposomes, since the negatively charged phospholipids tend to increase the interbilayer distance owing to electrostatic repulsive forces, which avoid aggregation among vesicles [25]. The addition of PEP to the bilayers led to initial decreases in the zeta potential.

    View all citing articles on Scopus
    View full text